Encompass Health Co. (NYSE:EHC) Shares Purchased by BNP Paribas Financial Markets

BNP Paribas Financial Markets raised its position in Encompass Health Co. (NYSE:EHC - Free Report) by 38.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 38,397 shares of the company's stock after buying an additional 10,591 shares during the period. BNP Paribas Financial Markets' holdings in Encompass Health were worth $3,711,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the business. CIBC Asset Management Inc grew its stake in Encompass Health by 3.5% during the 3rd quarter. CIBC Asset Management Inc now owns 2,957 shares of the company's stock valued at $286,000 after purchasing an additional 100 shares in the last quarter. Commonwealth Equity Services LLC boosted its stake in shares of Encompass Health by 1.3% during the 2nd quarter. Commonwealth Equity Services LLC now owns 9,845 shares of the company's stock valued at $845,000 after buying an additional 123 shares during the last quarter. V Square Quantitative Management LLC grew its position in shares of Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company's stock worth $39,000 after buying an additional 140 shares in the last quarter. Verdence Capital Advisors LLC increased its stake in shares of Encompass Health by 4.6% in the third quarter. Verdence Capital Advisors LLC now owns 3,670 shares of the company's stock worth $355,000 after buying an additional 160 shares during the last quarter. Finally, Mount Yale Investment Advisors LLC raised its holdings in Encompass Health by 6.6% in the second quarter. Mount Yale Investment Advisors LLC now owns 2,749 shares of the company's stock valued at $236,000 after acquiring an additional 170 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on EHC shares. Truist Financial reissued a "buy" rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. KeyCorp boosted their price objective on Encompass Health from $115.00 to $117.00 and gave the company an "overweight" rating in a report on Tuesday, October 29th. Barclays upped their price objective on Encompass Health from $109.00 to $116.00 and gave the company an "overweight" rating in a research note on Tuesday, October 29th. Royal Bank of Canada lifted their target price on Encompass Health from $105.00 to $110.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 30th. Finally, UBS Group upped their price target on Encompass Health from $100.00 to $110.00 and gave the company a "buy" rating in a research report on Wednesday, September 25th. Nine investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, Encompass Health has a consensus rating of "Buy" and an average price target of $107.11.

Encompass Health Stock Performance

EHC stock traded up $0.47 during mid-day trading on Thursday, reaching $102.87. The company had a trading volume of 690,006 shares, compared to its average volume of 640,231. Encompass Health Co. has a one year low of $64.15 and a one year high of $104.55. The stock has a market capitalization of $10.36 billion, a P/E ratio of 24.72, a P/E/G ratio of 1.36 and a beta of 0.86. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock's 50-day simple moving average is $98.61 and its two-hundred day simple moving average is $91.77.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The firm had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same period last year, the firm posted $0.86 EPS. Encompass Health's quarterly revenue was up 11.9% compared to the same quarter last year. Research analysts anticipate that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.66%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health's payout ratio is currently 16.43%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.